- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05759065
A Hybrid Effectiveness Implementation Trial Evaluating Behavioral Treatments for Insomnia for Socioeconomically Disadvantaged Adults in Primary Care
April 2, 2024 updated by: Suzanne M. Bertisch, MD, MPH, Brigham and Women's Hospital
The overall objective of this study is to conduct a randomized effectiveness-implementation trial to test the non-inferiority of tele-Brief Behavioral Treatment for Insomnia vs. tele-Cognitive-Behavioral Therapy for Insomnia among socioeconomically disadvantaged adults with insomnia in the primary care setting.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
350
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Suzanne Bertisch, MD, MPH
- Phone Number: 857-307-0355
- Email: sbertisch@bwh.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Brigham and Women's Hospital
-
Contact:
- Carolina Dos Santos
- Phone Number: 617-278-0746
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged 18 years or older
- Meet clinical diagnostic criteria for insomnia
- Insomnia severity score > 10
- Eligible to receive care through publicly supported medical assistance, OR
- Identify as race or ethnic minority
- Has capacity for informed consent
Exclusion Criteria:
- Untreated, current major depressive disorder
- History of bipolar or psychosis
- Active substance abuse or drug abuse
- Excessive daytime sleepiness
- Seizure within the past 1 year
- Main sleep period outside of 8pm - 11am
- Regular nightshift work
- Untreated, previously diagnosed moderate to severe sleep apnea
- Severe medical condition, which may require hospitalizations over the next 6 months
- Active suicidal ideation, if elicited passively during screening
- Pregnant or planning to become pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Tele-Brief Behavioral Treatment for Insomnia
|
Brief Behavioral Treatment for Insomnia (BBTI) comprises of up to five weekly intervention visits by phone, delivered by a variety of practitioners without formal training in sleep.
|
Active Comparator: Tele-Cognitive-Behavioral Therapy for Insomnia
|
Cognitive-Behavioral Therapy for Insomnia (CBTI) is a multicomponent strategy delivered by trained mental health clinicians over 6 to 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insomnia severity index, ISI
Time Frame: 3 months
|
The Insomnia Severity Index is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia in the last month.
A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28.
The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insomnia severity index, ISI
Time Frame: 6- and 12-months
|
The Insomnia Severity Index is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia in the last month.
A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28.
The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).
|
6- and 12-months
|
Quality of Life and Symptoms - Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health
Time Frame: 3-months
|
The PROMIS Global Health measures assess an individual's physical, mental and social health.
The measure produces two scores: Physical and Mental Health from 4 items each.
Item responses are combined to yield a T-score with a population mean of 50 and standard deviation of 10.
|
3-months
|
Quality of Life and Symptoms - Generic-quality of life
Time Frame: 3-months
|
Generic-quality of life will be assessed by the change in the Euroqol - 5 Dimensions (EQ-5D) questionnaire.
The questionnaire comprises of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 3 levels: no problems, some problems, and extreme problems.
There is no total score or range.
|
3-months
|
Generalized Anxiety Disorder (GAD-7)
Time Frame: 3-months
|
GAD-7 measures self-reported anxiety disorder.
The measure includes 7-items with higher scores indicating anxiety.
The minimum score is 0 and the maximum score is 21.
|
3-months
|
Patient Health Questionnaire for depression (PHQ-8)
Time Frame: 3-months
|
PHQ-8 measures self-reported current depression.
The measure includes 8-items with higher scores indicating depression.
The minimum score is 0 and the maximum score is 24.
|
3-months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Impairment, 8a
Time Frame: 3-months
|
PROMIS Sleep Impairment measures self-reported perceptions of alertness, sleepiness, and tiredness during usual waking hours, and the perceived functional impairments during wakefulness associated with sleep problems or impaired alertness during the past seven days.
The measure includes 8-items with higher scores indicating greater sleep impairment.
The minimum score is 8 and the maximum score 40.
Item responses are combined to yield a T-score with a population mean of 50 and standard deviation of 10.
|
3-months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance, 8b
Time Frame: 3-months
|
PROMIS Sleep Disturbance measures self-reported sleep quality and associated daytime functioning during the past seven days.
The measure includes 8-items with higher scores indicating greater sleep disturbance.
The minimum score is 8 and the maximum score is 40.
Item responses are combined to yield a T-score with a population mean of 50 and standard deviation of 10.
|
3-months
|
Diary reported sleep duration
Time Frame: 3-months
|
Self-reported sleep duration with be measured using sleep diary
|
3-months
|
Diary-reported sleep efficiency
Time Frame: 3-months
|
Self-reported sleep efficiency with be measured using sleep diary
|
3-months
|
Number of participants with hypnotic use self-reported from the sleep diary
Time Frame: 3-months
|
Hypnotic use will be measured by the number of participants who self-reported use on the sleep diary
|
3-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 2, 2024
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Study Registration Dates
First Submitted
February 8, 2023
First Submitted That Met QC Criteria
February 25, 2023
First Posted (Actual)
March 8, 2023
Study Record Updates
Last Update Posted (Actual)
April 4, 2024
Last Update Submitted That Met QC Criteria
April 2, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023P000106
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Sunshine Lake Pharma Co., Ltd.Unknown
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
-
Butler HospitalSunovionCompleted
Clinical Trials on Tele-Brief Behavioral Treatment for Insomnia
-
VA Pittsburgh Healthcare SystemVA Office of Research and DevelopmentCompleted
-
National Cheng-Kung University HospitalRecruitingOlder Adults | Chronic Insomnia | Sleep HygieneTaiwan
-
VA Pittsburgh Healthcare SystemCompletedInsomnia | Treatment Resistant DepressionUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedChronic InsomniaUnited States
-
State University of New York at BuffaloNational Institute of Nursing Research (NINR); Roswell Park Cancer InstituteCompleted
-
VA Office of Research and DevelopmentUniversity of California, San FranciscoCompleted
-
Hospital General de MexicoEnrolling by invitationDepression | Anxiety | Sleep Quality | Insomnia Chronic | Life QualityMexico
-
University of California, San DiegoWithdrawnStage, Breast CancerUnited States
-
VA Office of Research and DevelopmentRecruitingBrief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder (BBTI & PTSD)Posttraumatic Stress Disorder | Insomnia DisorderUnited States
-
Nagoya City UniversityKochi UniversityCompletedMajor Depressive DisorderJapan